Original Paper

Parasitology Research

, Volume 88, Issue 5, pp 395-397

First online:

Chemotherapeutic approaches to schistosomes: current knowledge and outlook

  •  A. HarderAffiliated withBiological Chemical Evaluation, Animal Health Business Group Bayer AG Monheim, 51368 Leverkusen, Germany

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


The chemotherapy of schistosomiasis has improved greatly in the last few decades. There are three drugs available: metrifonate (active against Schistosoma haematobium), oxamniquine (active against Schistosoma mansoni) as narrow spectrum drugs and praziquantel, which is effective against all important adult schistosome species and their immature stages, as the drug of choice.